Measles medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:


==Medical Therapy==
==Medical Therapy==
According to current data, there is no [[Antiviral treatment|antiviral therapy]] for [[measles]] [[infection]] and standard treatment is focused on supportive care. Yet, case reports have noted the ''in vitro'' susceptibility of [[measles virus]] to [[ribavirin]]. [[Ribavirin]], in parallel with other [[drugs]], such as [[interferon-α]] have been used in more severe cases of [[measles]], specially when in the presence of [[CNS infection]].<ref name="MossGriffin2012">{{cite journal|last1=Moss|first1=William J|last2=Griffin|first2=Diane E|title=Measles|journal=The Lancet|volume=379|issue=9811|year=2012|pages=153–164|issn=01406736|doi=10.1016/S0140-6736(10)62352-5}}</ref>
According to current data, there is no [[Antiviral Therapy|antiviral therapy]] for [[measles]] [[infection]] and standard treatment is focused on supportive care. Yet, case reports have noted the ''in vitro'' susceptibility of [[measles virus]] to [[ribavirin]]. [[Ribavirin]], in parallel with other [[drugs]], such as [[interferon-α]] have been used in more severe cases of [[measles]], specially when in the presence of [[CNS infection]].<ref name="MossGriffin2012">{{cite journal|last1=Moss|first1=William J|last2=Griffin|first2=Diane E|title=Measles|journal=The Lancet|volume=379|issue=9811|year=2012|pages=153–164|issn=01406736|doi=10.1016/S0140-6736(10)62352-5}}</ref><ref name="pmid20390298">{{cite journal| author=Reuter D, Schneider-Schaulies J| title=Measles virus infection of the CNS: human disease, animal models, and approaches to therapy. | journal=Med Microbiol Immunol | year= 2010 | volume= 199 | issue= 3 | pages= 261-71 | pmid=20390298 | doi=10.1007/s00430-010-0153-2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20390298  }} </ref>


==References==
==References==

Revision as of 15:42, 24 June 2014

Measles Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Measles from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Measles medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Measles medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Measles medical therapy

CDC on Measles medical therapy

Measles medical therapy in the news

Blogs on Measles medical therapy

Directions to Hospitals Treating Measles

Risk calculators and risk factors for Measles medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Despite the efforts made in the past years to develop a treatment regimen for measles, there is still no specific antiviral therapy for uncomplicated cases of measles, however, some drugs such as ribavirin and interferon-α have been used in the more severe cases of the condition, notably for cases of infection of the CNS by the virus. Yet, there is evidence that the administration of two doses of vitamin A in children, under the age of two, was associated with a reduced risk of morbidity and mortality from the disease. For most patients with measles, the standard treatment is focused on supportive care.[1][2][3]

Medical Therapy

According to current data, there is no antiviral therapy for measles infection and standard treatment is focused on supportive care. Yet, case reports have noted the in vitro susceptibility of measles virus to ribavirin. Ribavirin, in parallel with other drugs, such as interferon-α have been used in more severe cases of measles, specially when in the presence of CNS infection.[1][3]

References

  1. 1.0 1.1 Moss, William J; Griffin, Diane E (2012). "Measles". The Lancet. 379 (9811): 153–164. doi:10.1016/S0140-6736(10)62352-5. ISSN 0140-6736.
  2. Huiming Y, Chaomin W, Meng M (2005). "Vitamin A for treating measles in children". Cochrane Database Syst Rev (4): CD001479. doi:10.1002/14651858.CD001479.pub3. PMID 16235283.
  3. 3.0 3.1 Reuter D, Schneider-Schaulies J (2010). "Measles virus infection of the CNS: human disease, animal models, and approaches to therapy". Med Microbiol Immunol. 199 (3): 261–71. doi:10.1007/s00430-010-0153-2. PMID 20390298.

Template:WH Template:WS